CarMax operates a nationwide network of used vehicle retail stores, offering financing and ancillary services to U.S. consumers.On January 22, Courant Investment Management disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold out its entire position in CarMax (KMX 3.22%), with the estimated transaction value at $11.11 million.What happenedAccording to a SEC filing dated January 22, Courant Investment Management sold its entire stake of 247,520 CarMax shares. The position’s quarte ...

Capital Rotation - There has been a notable capital rotation from growth and technology sectors into value and high-quality dividends in recent weeks [1]

Axie Infinity, The Sandbox, and other gaming tokens have notched significant gains as Bitcoin trades lower amid escalating global liquidity threats. Over the past 24 hours, Axie Infinity is up 16.7%, bringing its weekly gains to 88.5%, according to CoinGecko data. Over the past week, The Sandbox has recorded a rally of 15.3%, while gaming tokens including Decentraland and Smooth Love Potion have also posted weekly gains of 4.4% and 0.7% respectively. The moves signal a potential rotation in trader focus. ...

Core Thesis - Sila Realty Trust, Inc. (SILA) presents a compelling investment opportunity with a 7% dividend yield and a focus on healthcare properties, operating under a net lease model similar to NNN REIT [2][3] Company Overview - Sila Realty Trust specializes in healthcare properties, including medical office buildings, rehabilitation centers, and surgical facilities [2] - The company utilizes triple net leases averaging 10 years in duration with annual 2% rent escalations, providing predictable and stable cash flows [3] Financial Metrics - Sila's rent coverage ratio is approximately 5.3x, indicating strong tenant reliability [3] - The company's debt to EBITDA ratio stands at about 3.6x, allowing for strategic acquisitions while retaining roughly 25% of cash flow [3] - Funds from Operations (FFO) per share is projected to grow at an annual rate of 4-6% [3] Market Conditions - Broader market conditions are favorable for Sila, as fixed income investments have drawn significant capital due to recent rate hikes, but the attractiveness of these investments is diminishing with anticipated rate cuts by the Federal Reserve [4] - This shift may lead to a rotation back into high-yielding equity sectors, particularly REITs, which are currently trading near decade-low valuations [5] Investment Potential - Sila's combination of resilient cash flows, a strong balance sheet, and a 7% dividend positions it well to benefit from potential capital inflows as the market re-evaluates high-quality REITs [5]

Key Takeaways Crypto investment products saw $454 million in net outflows last week, reversing early 2026 inflows. U.S.-based products drove the decline with $569 million in outflows, while Europe and Canada posted inflows. Bitcoin led losses, but XRP and Solana attracted fresh capital. Crypto investment products recorded $454 million in net outflows in the second week of January, interrupting the bullish momentum that marked the start of 2026. The pullback followed a shift in macroeconomic expec ...

Gold and silver surged during the Asian market open, while Bitcoin struggled to maintain momentum amid escalating tensions between the Federal Reserve (Fed) and the Trump administration, triggering a flight to traditional safe havens. The divergence intensified after the Department of Justice’s actions against Fed Chair Jerome Powell sparked concerns about central bank independence, with gold climbing 1.72% and silver soaring over 4.5% in 24 hours, while Bitcoin retreated sharply from $92,000 to $90,000. ...

Core Insights - Aristides Capital has fully exited its position in the iShares Biotechnology ETF, liquidating approximately $3.60 million worth of shares, indicating a strategic shift away from sector beta after a strong biotech rebound [1][2][5] Fund Performance - The iShares Biotechnology ETF (IBB) has seen a price increase of 28% over the past year, closing at $171.88, significantly outperforming the S&P 500, which rose about 15% in the same timeframe [3][4] - Year-to-date gains for the ETF exceed 30%, with a trailing one-year return of 14.49% [4][6] ETF Overview - The iShares Biotechnology ETF has an Assets Under Management (AUM) of $8.68 billion and an expense ratio of 0.44%, providing exposure to over 250 biotechnology stocks [4][8] - The ETF aims to replicate the performance of a biotechnology sector index, focusing on disciplined portfolio construction to manage sector-specific risks [4][8] Investment Strategy - Exiting a broad biotech ETF amid a strong market run reflects a deliberate capital rotation strategy rather than a bearish outlook, as the fund maintains significant positions in other market beta assets [5][9] - The current market environment favors selective investments over broad sector ETFs, suggesting that alpha generation will come from targeted stock selection rather than diversified baskets [9]

Core Insights - Dogecoin and Shiba Inu experienced declines during U.S. trading hours, driven by increased sell volume that pushed both tokens below significant technical levels, indicating a broader weakness in the meme coin segment while ether underperformed compared to other major cryptocurrencies [1][2] - The observed divergence in performance suggests a capital rotation and de-risking trend rather than a panic selling scenario, as broader crypto benchmarks remained relatively stable [1] Group 1: Market Dynamics - Ether (ETH) showed continued softness, often viewed as a proxy for risk appetite in altcoins, which contributed to higher-beta assets like meme coins facing significant selling pressure [2] - Dogecoin fell below the psychological threshold of $0.13 after failing to maintain above $0.1331, confirming a pattern of lower highs and establishing a descending price channel [2] - Trading volume for Dogecoin surged by 53% to 479.7 million tokens, indicating active distribution rather than a result of low liquidity [2] Group 2: Technical Analysis - The previous support level around $0.1296 has now turned into resistance, reinforcing a bearish market structure for Dogecoin [2] - Shiba Inu followed a similar trend to Dogecoin, slipping below short-term support and failing to reclaim the overhead supply, indicating sector-wide pressure rather than isolated weakness in individual tokens [2] - The inability to reclaim broken levels raises the likelihood of continued movement towards lower demand zones unless there is decisive buying activity [2]

🔥 $BTC looks alive again, but the next move will not be random.Macro liquidity, risk appetite and capital rotation are lining up for a major decision point.We mapped out the possible paths.Full report inside.https://t.co/WvOsjMNYYB ...

Group 1 - Institutional money managers commonly rotate capital among the most liquid stocks, typically within the S&P 500 index, throughout the year [1] - Daniel Sereda serves as the chief investment analyst at a family office, managing investments across various asset classes and continents [1] - The investing group Beyond the Wall Investing provides access to critical information prioritized by institutional market participants [1]